Wyeth FluShield shipments
Executive Summary
Wyeth-Ayerst plans to ship the first lots of its flu vaccine FluShield following FDA's Oct. 16 sBLA approval for process improvements at Wyeth's Marietta, Penn. plant. FDA released 13 lots for distribution as of Oct. 16; 55 lots of Aventis Pasteur's Fluzone and 14 lots of Powderject's Fluvirin have also been released
You may also be interested in...
National Vaccine Facility Would Not Solve Current Shortages, CDC Says
A national vaccine facility would not solve near-term supply problems, Centers for Disease Control & Prevention National Immunization Program Director Walter Orenstein, MD, suggested
National Vaccine Facility Would Not Solve Current Shortages, CDC Says
A national vaccine facility would not solve near-term supply problems, Centers for Disease Control & Prevention National Immunization Program Director Walter Orenstein, MD, suggested
Wyeth Prevnar Supply “Bottleneck” Will Let Up In Mid-2002, Firm Says
Wyeth-Ayerst hopes to wrap-up discussions with FDA over the product release process for Prevnar to alleviate a supply "bottleneck" by mid-2002